Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Compulink Showcases AI-Powered, All-in-One Orthopaedic EHR Solution at ASES 2019


Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will showcase its Orthopaedic Advantagetm suite of Ortho-specific solutions at the American Shoulder and Elbow Surgeons annual meeting from October 16-19, 2019 in New York, NY.

Designed to maximize efficiencies and improve profitability, Advantage uses real-time data to automate tasks and streamline patient flow. Features include:

"Our goal is to maximize the efficiency of the entire staff during the patient encounter to drive down costs and improve the patient experience," said Link Wilson, CEO and product architect for Compulink. Our Advantage SMART Practice solution handles all of the needs of a patient encounter, reducing repetitive steps to enable the practice to see more patient with the same staff and improve their bottom line by as much as 40%."

Designed specifically for frontline orthopaedic providers, Advantage includes EHR supporting all Ortho sub-specialties, practice management, PACS integration, inventory management, mobile patient engagement, and a comprehensive ASC solution. The company also provides an expert revenue cycle management service for its clients. Advantage is 2015 ONC Certified for MIPS and is used by more than 20,000 providers in over 4,700 locations, 60 ASCs, and 19 universities and colleges.

Attendees at ASES can demo Orthopaedic Advantage at booth 5.

About Compulink Healthcare Solutions

A leader in specialty-specific, all-in-one EHR and Practice Management solutions for 34 years, Compulink's Advantage SMART Practice® uses artificial intelligence to improve clinical and financial results. Designed to maximize your time while seeing patients, Advantage includes everything you need to optimize workflow including EHR, PM, ASC, patient engagement, and RCM.


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: